A VHL-HIF signaling axis orchestrates invariant natural killer T cell development and fate decisions
Li et al. show that the VHL-HIF axis controls invariant NKT cell development. VHL loss stabilizes HIF1α, which drives iNKT cell apoptosis and blocks iNKT2 fate via mitochondrial metabolism, and HIF2α, which suppresses iNKT17 specification through IL2RA-STAT5 signaling, impairing antitumor immunity.